Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 13
Submit an article Journal homepage
170
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemia

Rithin Nedumannila Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0883-3942View further author information
ORCID Icon,
Emily Batterhama Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, AustraliaView further author information
,
Emily Hardingb Department of Pharmacy, The Royal Melbourne Hospital, Parkville, AustraliaView further author information
,
David Ritchiea Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia;c Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia;d Department of Medicine, The University of Melbourne, Parkville, AustraliaView further author information
,
Andrew Weia Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia;e Division of Blood Cells and Blood Cancers, Walter and Eliza Hall Institute of Medical Research, Melbourne, AustraliaView further author information
&
Ashish Bajela Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia;c Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, AustraliaORCID Iconhttps://orcid.org/0000-0002-3755-7334View further author information
ORCID Icon
Pages 2123-2132 | Received 18 Apr 2023, Accepted 15 Aug 2023, Published online: 01 Sep 2023

References

  • Roloff GW, Odenike O, Bajel A, et al. Contemporary approach to acute myeloid leukemia therapy in 2022. Am Soc Clin Oncol Educ Book. 2022; 42:1–16. doi:10.1200/EDBK_349605
  • Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and leukemia group B. N Engl J Med. 1994;331(14):896–903. doi:10.1056/NEJM199410063311402
  • Schaich M, Röllig C, Soucek S, et al. Cytarabine dose of 36 g/m2 compared with 12 g/m2 within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study. J Clin Oncol. 2011;29(19):2696–2702. doi:10.1200/JCO.2010.33.7303
  • Löwenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027–1036. doi:10.1056/NEJMoa1010222
  • Löwenberg B. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood. 2013;121(1):26–28. doi:10.1182/blood-2012-07-444851
  • Dumas PY, Bertoli S, Bérard E, et al. Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome. Blood Adv. 2020;4(16):3840–3849. doi:10.1182/bloodadvances.2020002511
  • Miyawaki S, Ohtake S, Fujisawa S, et al. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 study. Blood. 2011;117(8):2366–2372. doi:10.1182/blood-2010-07-295279
  • Jaramillo S, Benner A, Krauter J, et al. Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia. Blood Cancer J. 2017;7(5):e564–e564. doi:10.1038/bcj.2017.45
  • Schlenk RF. Post-remission therapy for acute myeloid leukemia. Haematologica. 2014;99(11):1663–1670. doi:10.3324/haematol.2014.114611
  • Burnett AK, Russell NH, Hills RK, et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol. 2013;31(27):3360–3368. doi:10.1200/JCO.2012.47.4874
  • Sperr WR, Piribauer M, Wimazal F, et al. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). Clin Cancer Res. 2004;10(12 Pt 1):3965–3971. doi:10.1158/1078-0432.CCR-04-0185
  • Grimwade D, Walker H, Oliver F, et al. The medical research council adult and children’s leukaemia working parties. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92(7):2322–2333. doi:10.1182/blood.V92.7.2322
  • Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–1377. doi:10.1182/blood.2022016867
  • Lykon J, Madarang E, Nguyen N, et al. Use of high dose cytarabine (HiDAC) for post-remission or re-induction therapy is safe and effective in select older AML patients. Blood. 2021;138(Supplement 1):4422–4422. doi:10.1182/blood-2021-153143
  • Gonen C, Celik I, Cetinkaya YS, et al. Cytarabine-induced fever complicating the clinical course of leukemia. Anticancer Drugs. 2005;16(1):59–62. doi:10.1097/00001813-200501000-00008

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.